Michael Barbella, Managing Editor01.24.23
Ur24Technology Inc. has launched the TrueClr catheter product line, a latex-free external product designed to actively empty adult and pediatric bladders.
“I am convinced the TrueClr external catheters will fundamentally revolutionize medical practices," Ur24Technology Medical Director Jon Meliones, M.D., said. "It’s an active elimination system vs. passive—the only catheter of its kind in the world.”
The TrueClr line is designed to give eliminate catheter-associated urinary tract infections in hospitals, increase patient comfort and quality of life, and lower healthcare costs. U.S. data shows that internal catheters are associated with 80% of hospital-related urinary tract infections, which cost the health care system an estimated $450 million annually. Nearly 13,000 deaths annually are related to internal catheters.
Key features of the TrueClr product line include:
Ur24 Technology has forged a strategic partnership with Miami-based DemeTECH Corp. to manufacture and distribute TrueClr products in the United States and internationally, using its distribution network in 132 countries.
Ur24Technology, Inc. is a privately held medical device company located in Southern California that was founded in 2016 by Landon Duval. Five different external catheter prototypes were researched, designed and developed, leading to the TrueClr external catheter range of products.
DemeTECH, is a developer of surgical sutures, mesh and bone wax. DemeTECH’s N95 masks and TrueClr external catheters are made in the United States with American materials.
“I am convinced the TrueClr external catheters will fundamentally revolutionize medical practices," Ur24Technology Medical Director Jon Meliones, M.D., said. "It’s an active elimination system vs. passive—the only catheter of its kind in the world.”
The TrueClr line is designed to give eliminate catheter-associated urinary tract infections in hospitals, increase patient comfort and quality of life, and lower healthcare costs. U.S. data shows that internal catheters are associated with 80% of hospital-related urinary tract infections, which cost the health care system an estimated $450 million annually. Nearly 13,000 deaths annually are related to internal catheters.
Key features of the TrueClr product line include:
- Eliminates internal catheter-associated urinary tract infections
- Uses light, continuous section
- Non-invasive, non-adhesive, comfortable
- Leak proof design
- Avoids urine contact with skin
- Eliminates skin irritation and inflammation
- Portable & reusable – in hospitals or at home, with easy cleaning
- Covered under Medicare Part B, DME reimbursement
Ur24 Technology has forged a strategic partnership with Miami-based DemeTECH Corp. to manufacture and distribute TrueClr products in the United States and internationally, using its distribution network in 132 countries.
Ur24Technology, Inc. is a privately held medical device company located in Southern California that was founded in 2016 by Landon Duval. Five different external catheter prototypes were researched, designed and developed, leading to the TrueClr external catheter range of products.
DemeTECH, is a developer of surgical sutures, mesh and bone wax. DemeTECH’s N95 masks and TrueClr external catheters are made in the United States with American materials.